| Quarterly Financials | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 21 | 24 | 24 | 32 | 34 | 39 | 37 | 46 | 48 | 46 |
| Expenses | 16 | 20 | 18 | 24 | 26 | 29 | 29 | 36 | 36 | 38 |
| EBITDA | 5 | 4 | 5 | 8 | 8 | 10 | 8 | 10 | 12 | 8 |
| Operating Profit % | 20 % | 16 % | 21 % | 22 % | 21 % | 18 % | 20 % | 20 % | 22 % | 17 % |
| Depreciation | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 1 | -1 | 2 | 4 | 4 | 5 | 4 | 6 | 7 | 5 |
| Tax | 1 | -1 | 0 | 1 | 1 | 2 | 1 | 2 | 2 | 1 |
| Net Profit | -0 | -0 | 2 | 3 | 3 | 4 | 3 | 4 | 5 | 4 |
| EPS in ₹ | -0.03 | -0.18 | 0.74 | 1.45 | 1.36 | 1.82 | 1.59 | 2.13 | 2.76 | 1.99 |
Asarfi Hospital
Asarfi Hospital
190.85
-3.60
(-1.85%)
Market Cap
375.52 Cr
PE Ratio
22.96
Volume
22,000.00
Day High - Low
198.90 - 190.40
52W High-Low
256.95 - 106.63
There are 1 new updates from the company1 day ago
View
Key Fundamentals
Market Cap
375.52 Cr
EPS
8.47
PE Ratio
22.96
PB Ratio
3.92
Book Value
49.62
EBITDA
35.27
Dividend Yield
0.00 %
Industry
Healthcare Services Sector
Hospitals Return on Equity
13.06
Debt to Equity
0.53
Actual
Company News
View All News
Asarfi Hospital Limited will hold an analyst conference call on May 25, 2026, to discuss audited financial results for Q4 and FY ended March 31, 2026.
Asarfi Hospital posted 42% YoY revenue growth in FY26 to ₹173.5 Cr, with PAT up 58% to ₹16.7 Cr. Audited results published in Times of India and Dainik Jagran on May 12, 2026.
Asarfi Hospital's Board approved FY26 audited results on May 11, 2026. Standalone revenue rose to ₹17,319.69 lakhs and net profit to ₹1,707.66 lakhs, with unmodified audit opinion from R.K. Thakkar & Co.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
8,362.50 | #1 1,20,239.92 | 59.62 | #1 25,228.50 | 14.70 | #1 2,032 | 33.00 | 72.11 | |
1,023.25 | 99,576.04 | 74.87 | 7,184.10 | #1 28.68 | 1,076 | 7.27 | 49.03 | |
960.40 | 72,506.18 | 74.45 | 7,849.70 | 13.25 | 809 | -22.38 | 58.34 | |
756.60 | 39,201.04 | 92.03 | 4,643.22 | 8.32 | 384 | #1 79.65 | 63.54 | |
1,855.60 | 37,921.19 | 50.58 | 5,575.00 | 12.29 | 790 | -34.33 | 54.08 | |
1,238.10 | 33,278.94 | 60.16 | 4,410.27 | 16.94 | 584 | 39.64 | 65.94 | |
764.10 | 30,574.62 | 127.24 | 3,904.60 | 27.31 | 198 | -68.80 | 61.12 | |
479.35 | 15,186.17 | 94.81 | 1,757.00 | 27.64 | 110 | 17.65 | 65.11 | |
1,355.00 | 13,761.27 | 52.57 | 1,566.90 | 17.46 | 244 | 7.26 | 66.76 | |
259.19 | 11,195.22 | #1 40.39 | 1,679.36 | 17.77 | 272 | 46.56 | 67.30 |
Growth Rate
Revenue Growth
35.44 %
Net Income Growth
53.87 %
Cash Flow Change
-116.69 %
ROE
120.98 %
ROCE
83.68 %
EBITDA Margin (Avg.)
-17.48 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2024 | 2025 | 2026 |
| Total Assets | 154 | 164 | 193 |
| Fixed Assets | 94 | 102 | 110 |
| Current Assets | 46 | 59 | 71 |
| Capital Work in Progress | 0 | 2 | 2 |
| Investments | 0 | 0 | 3 |
| Other Assets | 60 | 60 | 0 |
| Total Equity & Liabilities | 154 | 164 | 193 |
| Current Liabilities | 44 | 41 | 49 |
| Non Current Liabilities | 39 | 42 | 46 |
| Total Equity | 70 | 81 | 98 |
| Reserve & Surplus | 51 | 61 | 78 |
| Share Capital | 20 | 20 | 20 |
Cash Flow
| Cash Flow | 2024 | 2025 |
| Net Cash Flow | -1 | 1 |
| Investing Activities | -63 | -7 |
| Operating Activities | 26 | -4 |
| Financing Activities | 36 | 13 |
Share Holding
| % Holding | Mar 2023 | Jul 2023 | Sept 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 83.03 % | 61.17 % | 61.17 % | 61.17 % | 61.17 % | 61.17 % | 61.17 % | 61.17 % | 61.17 % | 61.17 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.10 % | 0.05 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.37 % | 3.25 % | 2.33 % | 1.95 % | 2.92 % | 3.18 % | 2.19 % | 1.98 % | 2.40 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 23.73 % | 27.40 % | 31.63 % | 32.99 % | 30.86 % | 29.89 % | 30.89 % | 31.72 % | 30.63 % |
| Others | 16.97 % | 14.74 % | 8.18 % | 4.87 % | 3.89 % | 5.05 % | 5.66 % | 5.70 % | 5.13 % | 5.79 % |
| No of Share Holders | 37 | 1,248 | 706 | 1,261 | 1,284 | 1,262 | 1,176 | 1,167 | 1,225 | 1,316 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 30 Jan 2024 |  Extraordinary General Meeting | NA | 30 Jan 2024 | 83.07 | 94.14 |
| 13 Sept 2024 |  Annual General Meeting | NA | 13 Sept 2024 | 62.88 | 63.15 |
| 30 Oct 2024 |  Quarterly Result Announcement | NA | 30 Oct 2024 | 59.99 | 63.60 |
| 31 Jan 2025 | Quarterly Result Announcement | NA | 31 Jan 2025 | 93.67 | 94.88 |
| 08 May 2025 | Quarterly Result Announcement | NA | 08 May 2025 | 89.81 | 94.41 |
| 07 Aug 2025 | Quarterly Result Announcement | NA | 07 Aug 2025 | 131.05 | 128.25 |
| 12 Sept 2025 | Annual General Meeting | NA | 12 Sept 2025 | 126.50 | 147.00 |
| 10 Nov 2025 | Quarterly Result Announcement | NA | 10 Nov 2025 | 143.00 | 143.00 |
| 09 Feb 2026 | Quarterly Result Announcement | NA | 09 Feb 2026 | 183.75 | 186.50 |
| 11 May 2026 | Quarterly Result Announcement | NA | 11 May 2026 | 216.00 | 252.80 |
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 11, 2026
May 11, 2026Announcement under Regulation 30 (LODR)-Investor PresentationMay 11, 2026
May 11, 2026Submission Of Standalone & Consolidated Audited Financial Results For The Quarter And Year Ended 31St March 2026May 11, 2026
May 11, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On 11Th May 2026 And Submission Of Standalone & Consolidated Audited Financial Results For The Quarter And Year Ended 31St March 2026 Pursuant To Regulation 33 Of SEBI (LODR) Regulations 2015May 11, 2026
May 11, 2026Board Meeting Intimation for Intimation Under Regulation 29(1)(A) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 04, 2026
May 04, 2026Closure of Trading WindowMar 27, 2026
Mar 27, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 10, 2026
Feb 10, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 09, 2026
Feb 09, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 09, 2026
Feb 09, 2026Submission Of Unaudited Financial Results For The Quarter Ended 31St December 2025Feb 09, 2026
Feb 09, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On 09 February 2026 And Submission Of Unaudited Financial Results For The Quarter Ended 31St December 2025.Feb 09, 2026
Feb 09, 2026Board Meeting Intimation for Consider And Adopt The Unaudited Financial Results For The Quarter Ended 31St December 2025 Along With The Limited Review Report Issued By M/S R. K. Thakkar & Co. Chartered Accountants.Feb 02, 2026
Feb 02, 2026Closure of Trading WindowDec 27, 2025
Dec 27, 2025Update Of Group Meeting Of Analyst/Institutional Investor Meetings Held On December 4 2025Dec 05, 2025
Dec 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 02, 2025
Dec 02, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 27, 2025
Nov 27, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 22, 2025
Nov 22, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 19, 2025
Nov 19, 2025Intimation Of Material Event - Grant Of AccreditationNov 17, 2025
Nov 17, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 15, 2025
Nov 15, 2025Submission Of Standalone & Consolidated Unaudited Financial Results For The Half Year Ended September 30 2025Nov 12, 2025
Nov 12, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 10, 2025
Nov 10, 2025Submission Of Standalone & Consolidated Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025Nov 10, 2025
Nov 10, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On November 10 2025 And Submission Of Standalone & Consolidated Unaudited Financial Results For The Quarter And Half Year Ended September 302025Nov 10, 2025
Nov 10, 2025Intimation Regarding Credit Rating - Asarfi Hospital Limited.Oct 13, 2025
Oct 13, 2025Closure of Trading WindowOct 11, 2025
Oct 11, 2025Board Meeting Outcome for Intimation Of Appointment Of Cost AuditorSep 25, 2025
Sep 25, 2025Disclosure Regarding Clerical Error In Debtors Ageing Statement In The Financial Statements For The Year Ended March 31 2025Sep 20, 2025
Sep 20, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 13, 2025
Sep 13, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 12, 2025
Sep 12, 2025Reg. 34 (1) Annual Report.Aug 21, 2025
Aug 21, 2025Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) 2015.Aug 20, 2025
Aug 20, 2025Board Meeting Intimation for Intimation Of Board Meeting For Consideration And Approval Of BoardS Report And Notice Of AGM.Aug 12, 2025
Aug 12, 2025Financial Result For Quarter Ended 30Th June2025Aug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 07, 2025
Aug 07, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 07Th August 2025 And Submission Of Unaudited Financial Results For The Quarter Ended 30Th June 2025.Aug 07, 2025
Aug 07, 2025Board Meeting Outcome for Reply To Discrepancy - Reason For Delay In Intimation Of Appointment Of Company Secretary And Compliance OfficerAug 06, 2025
Aug 06, 2025Board Meeting Intimation for Consider And Approve The Unaudited Financial Results Of The Company For The Quarter Ended 30Th June2025.Jul 31, 2025
Jul 31, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 06, 2025
Jun 06, 2025Appointment of Company Secretary and Compliance OfficerJun 04, 2025
Jun 04, 2025Board Meeting Outcome for Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Appointment Of Compliance Officer Cum Company Secretary.Jun 04, 2025
Jun 04, 2025Integrated Filing (Financial)May 24, 2025
May 24, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 19, 2025
May 19, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 14, 2025
May 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 12, 2025
May 12, 2025Technical Indicators
RSI(14)
Neutral 43.92
ATR(14)
Less Volatile 13.79
STOCH(9,6)
Oversold 16.91
STOCH RSI(14)
Oversold 7.33
MACD(12,26)
Bearish -5.71
ADX(14)
Strong Trend 27.47
UO(9)
Bearish 46.64
ROC(12)
Downtrend And Accelerating -16.92
WillR(14)
Oversold -81.22
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
